136 related articles for article (PubMed ID: 5211728)
1. [Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin].
Yourassowsky E; Schoutens E
Acta Clin Belg; 1971; 26(3):139-45. PubMed ID: 5211728
[No Abstract] [Full Text] [Related]
2. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
[TBL] [Abstract][Full Text] [Related]
3. New trends in the chemotherapy of staphylococcal infections.
Russo G; Tempera G; Stefani S; Nicoletti G
Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
[TBL] [Abstract][Full Text] [Related]
4. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Lowy FD; Chang DS; Lash PR
Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
Luna CM; Bruno D; Aruj P
Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
[No Abstract] [Full Text] [Related]
6. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Moorhouse EC; Mulvihill TE; Jones L; Mooney D; Falkiner FR; Keane CT
J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
[TBL] [Abstract][Full Text] [Related]
7. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
Del Bene VE; John JF; Twitty JA; Lewis JW
J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
[No Abstract] [Full Text] [Related]
8. Letter: Methicillin-resistant staphylococcus aureus.
Keane CT; Hone R
Lancet; 1974 Mar; 1(7855):458. PubMed ID: 4131463
[No Abstract] [Full Text] [Related]
9. In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Carricajo A; Vermesch R; Aubert G
Clin Microbiol Infect; 2001 Apr; 7(4):218-26. PubMed ID: 11422245
[No Abstract] [Full Text] [Related]
10. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1984; 30(2):102-12. PubMed ID: 6559664
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin- and methicillin-resistant Staphylococcus aureus: phenotypic and genotypic characterization of three putative nosocomial outbreak strains.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1996; 42(1):21-36. PubMed ID: 8751264
[TBL] [Abstract][Full Text] [Related]
12. Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece.
Tsakris A; Papadimitriou E; Douboyas J; Stylianopoulou F; Manolis E
Emerg Infect Dis; 2002 May; 8(5):536-7. PubMed ID: 11996696
[No Abstract] [Full Text] [Related]
13. Clinical implications of methicillin-resistance in Staphylococcus aureus.
Harris DM
Guys Hosp Rep; 1970; 119(2):145-54. PubMed ID: 5202526
[No Abstract] [Full Text] [Related]
14. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
Amirak ID; Li AK; Williams RJ; Noone P
J Infect; 1981 Mar; 3(1):50-8. PubMed ID: 6926536
[No Abstract] [Full Text] [Related]
15. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
16. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
[No Abstract] [Full Text] [Related]
17. Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.
Samra Z; Gadba R; Ofir O
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):425-7. PubMed ID: 11476446
[TBL] [Abstract][Full Text] [Related]
18. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.
Dacre JE; Emmerson AM; Jenner EA
Lancet; 1983 Oct; 2(8357):1036. PubMed ID: 6138588
[No Abstract] [Full Text] [Related]
19. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Waldvogel FA
J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
[No Abstract] [Full Text] [Related]
20. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
